Fidelity Investments’s Boundless Bio BOLD Stock Holding History

Fidelity Investments’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.45M	Sell	2,581,055 -114,400	-4%	-$176K	﹤0.01%	2329
2026 Q1	$2.96M	Buy	2,695,455 +11,433	+0.4%	+$13.4K	﹤0.01%	2499
2025 Q4	$3.22M	Sell	2,684,022 -414,049	-13%	-$516K	﹤0.01%	2431
2025 Q3	$3.81M	Sell	3,098,071 -27,032	-0.9%	-$31.2K	﹤0.01%	2326
2025 Q2	$3.16M	Sell	3,125,103 -32,669	-1%	-$43.4K	﹤0.01%	2327
2025 Q1	$4.77M	Sell	3,157,772 -187,234	-6%	-$388K	﹤0.01%	2167
2024 Q4	$9.7M	Buy	3,345,006 +6,922	+0.2%	+$20.2K	﹤0.01%	1949
2024 Q3	$11.6M	Sell	3,338,084 -96	-0%	-$348	﹤0.01%	1876
2024 Q2	$12.9M	Buy	3,338,180 +74,912	+2%	+$716K	﹤0.01%	1796
2024 Q1	$48.1M	Buy	+3,263,268	New	+$46.5M	﹤0.01%	1339

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Fidelity Investments's BOLD Position: Q2 2026 in Review

Fidelity Investments reduced its Boundless Bio (BOLD) stake by 4.2% in Q2 2026, selling an estimated $176K and leaving 2,581,055 shares worth $6.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

Fidelity Investments first reported a position in BOLD in Q1 2024 and has held it in 10 quarters since. The position peaked at $48.1M in Q1 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Fidelity Investments held 2,581,055 shares of Boundless Bio worth $6.45M as of Q2 2026.
Fidelity Investments sold 114,400 Boundless Bio shares in Q2 2026, an estimated $176K.
Boundless Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2329 holding.
Fidelity Investments first reported a position in Boundless Bio in Q1 2024 and has held it in 10 quarters since.
Fidelity Investments's Boundless Bio position peaked at $48.1M in Q1 2024.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.